News Archives | Page 41 of 46 | Precision For Medicine

June 3, 2013

ApoCell and Transgenomic Present Results of Lung Cancer Research Study at the 2013 ASCO Annual Meeting

HOUSTON and OMAHA, Neb., (June 3, 2013) – ApoCell, Inc. and Transgenomic, Inc. (OTCBB: TBIO) today announced the results of a research collaboration with the University of Texas MD Anderson Cancer Center that coupled ApoCell’s ApoStream™ platform for isolating circulating tumor cells (CTCs) with Transgenomic’s ICE COLD-PCR technology to detect […]

May 15, 2013

ApoCell Announces Delivery of First Prototypes of ApoStream® Circulating Tumor Cell (CTC) Isolation Device to National Cancer Institute

Houston (May 15, 2013) – ApoCell, Inc. announced that the first prototypes of its ApoStream™ circulating tumor cell (CTC) isolation system have been delivered to select investigator sites including SAIC-Frederick Inc. (SAIC-F) in support of the National Cancer Institute (NCI). The delivery is part of a $2.9 million subcontract awarded […]

April 2, 2013

Press Release: Precision for Medicine Appoints Karen Becker to Senior Leadership Team

Industry Expert in Regulatory Sciences and Commercial Strategy Joins New Service Organization Focused on Helping Life Science Companies Develop and Commercialize Next-Generation Medical Products (Bethesda, MD) April 8, 2013 – Precision for Medicine, Inc., (“Precision”) today announced that Karen Becker, PhD, has joined the company’s leadership team and will help […]